Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agilent Technologies (NY:A)

120.66 +0.21 (+0.17%)
Official Closing Price Updated: 7:00 PM EDT, Jul 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Agilent Technologies

< Previous 1 2 3 4 5 6 7 8 9 Next >
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces the Cary 3500 UV-Vis Spectrophotometer Compatibility with OpenLab
From Agilent Technologies Inc.
Via Business Wire
Agilent to Present at Evercore ISI Virtual Healthcare Conference
From Agilent Technologies Inc.
Via Business Wire
Agilent Reports Fourth-Quarter and Fiscal Year 2021 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Dr. Otis Brawley Named to Agilent Board of Directors
From Agilent Technologies, Inc.
Via Business Wire
Agilent Increases Cash Dividend to 21 Cents Per Share
From Agilent Technologies, Inc.
Via Business Wire
Agilent Names John Palma to Lead Global Medical Affairs Organization
From Agilent Technologies, Inc.
Via Business Wire
Agilent Announces New Ion Mobility LC/Q-TOF and Enhanced Solutions for Biotherapeutics at ASMS 2021
From Agilent Technologies Inc.
Via Business Wire
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Triple-Negative Breast Cancer (TNBC)
From Agilent Technologies Inc.
Via Business Wire
Agilent to Webcast Fourth-Quarter Fiscal Year 2021 Financial Results Presentation
From Agilent Technologies Inc.
Via Business Wire
Agilent Commits to Net-Zero Greenhouse Gas Emissions by 2050
From Agilent Technologies, Inc.
Via Business Wire
Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
From Agilent Technologies Inc.
Via Business Wire
Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Thought Leader Award to Bernhard Lendl at the TU Wien (Vienna)
From Agilent Technologies Inc.
Via Business Wire
Dr. Mikael Dolsten Named to Agilent Board of Directors
From Agilent Technologies, Inc.
Via Business Wire
Agilent Announces Cash Dividend of 19.4 Cents per Share
From Agilent Technologies, Inc.
Via Business Wire
Agilent Announces Thought Leader Award to David R. Liu at the Broad Institute
From Agilent Technologies Inc.
Via Business Wire
Agilent and Visiopharm Expand Collaboration with Worldwide Distribution Agreement
From Agilent Technologies Inc.
Via Business Wire
Agilent to Present at Wells Fargo Virtual Healthcare Conference
From Agilent Technologies Inc.
Via Business Wire
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Esophageal Cancer
From Agilent Technologies Inc.
Via Business Wire
Researchers Develop COVID-19 Severity Screening Method Based on the Agilent Cary 630 FTIR Spectrometer
From Agilent Technologies Inc.
Via Business Wire
Agilent Reports Third-Quarter Fiscal Year 2021 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Agilent Earns 2021 Great Place to Work Certification in the U.S.
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Target Enrichment Manufacturing Facility in China
From Agilent Technologies Inc.
Via Business Wire
Agilent Early Career Professor Award Presented to Jason H. Yang
From Agilent Technologies Inc.
Via Business Wire
Clinical Utility of ALK Fusion Detection by Liquid Biopsy
From Agilent Technologies Inc.
Via Business Wire
Agilent Technologies Celebrates More than 20 Years of Sustainable Progress
From Agilent Technologies, Inc.
Via Business Wire
Agilent Technologies Celebrates More Than 20 Years of Sustainable Progress
SOURCE: 3BL Alerts 
Via 3BL Media
Topics Emissions
Agilent to Webcast Third-Quarter Fiscal Year 2021 Financial Results Presentation
From Agilent Technologies Inc.
Via Business Wire
Agilent PD-L1 IHC 22C3 pharmDx Expands CE-IVD mark in Non-small Cell Lung Cancer (NSCLC)
From Agilent Technologies Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.